This section covers all the questions that we were asked during the OMC. It will be updated regularly with answers to your questions.
Can wearable technologies be used?
Will the solution(s) be used in one single location in Turkey?
There may be one or more pilot locations in Turkey. But no more than two is expected.
Will we be able to reach the pilot patients’ health records?
Specified data from the EHR can be used only after the patient’s consent and after the signature of relevant agreements between the procurers and the suppliers. Patients’ health records may not be used for any other purpose except the project’s own goals. GDPR and local laws and regulations strictly apply.
The healthcare systems of the procurers are different. Are some solutions expected from only some perspectives, e.g., medical solutions only?
Comprehensive solutions that cover the whole INCAREHEART challenge are expected.
How specific will the Challenge Brief be? Will we be able to introduce our own ideas and approaches?
The Challenge Brief will explain the project challenge, stating some main specific requirements. The suppliers are welcome and indeed encouraged to introduce their own innovative approaches.
When will the Challenge Brief be published?
All call for tenders documents are planned to be published in November 2021.
Can we receive the Challenge Brief documents of ProEmpower and HSMonitor?
Yes, they will be made available on the project website.
Is it necessary to ensure interoperability with the Information Systems of all procurers?
CE Marks? What Medical Devices certification (I guess class IIa or IIb)?
The PCP process involves only testing the solution for usability and usefulness by users, but not certification. If the solution uses device or scales to measure clinical parameters, they must already be validated.
Do you already have an indication of which homecare devices should be integrated into the home solution to monitor the CHF patient?
No, the Buyers Group is open to devices fulfilling regulatory and quality standards.